On Tue, Sep 9, 2008 at 1:49 AM, skharoon <skhar
...@gmail.com> wrote:
> Hi,
> I have found one article on internet drug for TTP.
> Has any one knows about this....
> Pls reply.....
> --------------------------------------------------------------------------- ----------------------------------
> ARC1779 for TTP
> ARC1779 is currently in Phase 2 clinical development with a clinical
> trial designed to assess the safety, pharmacokinetics and
> pharmacodynamic effects of ARC1779 in approximately 28 patients with
> vWF-mediated platelet function disorders, including acute TTP.
> Archemix expects this trial to conclude in 3Q 2008.
> http://www.archemix.com/website/index.php
> http://www.archemix.com/website/products_1779_ttp.php
> Archemix' ARC1779 Granted Orphan Designation in EU for the Treatment
> of
> TTP, a Life-Threatening Blood Disorder
> http://www.archemix.com/website/_popup_press_release.php?release=49
> Archemix' ARC1779 Granted Orphan Designation for the Treatment of TTP,
> a
> Life-Threatening Blood Disorder
> http://www.archemix.com/website/_popup_press_release.php?release=48
> Archemix Announces Initiation of Phase 2 Trial for Aptamer Product
> Candidate ARC1779 in Patients with TTP, a Rare, Life-Threatening Blood
> Disorder
> http://www.archemix.com/website/_popup_press_release.php?release=47
> Product Pipeline
> http://www.archemix.com/website/products.php
> --------------------------------------------------------------------------- ----------------------------------